ENDOTIS

Welcome to the Brand page for “ENDOTIS”, which is offered here for Pharmaceutical preparations and veterinary preparations; molecules for therapeutic use, proteins, peptides, nucleic acids, small synthetic molecules, in particular for the treatment of cancer and inflammatory pathologies, especially aggressive and metastasis cancer and acute inflammatory pathologies; diagnostic products, reagents, biological and pharmaceutical preparations for detecting the presence or evaluating the progression of a disease, for evaluating the response to a treatment or the prognosis of a patient outcome; biological preparations for medical, pharmaceutical or veterinary purposes for the treatment of cancer, inflammatory pathologies, and neurodegenerative diseases; culture medium for bacteriological use, nutritive substances for microorganisms; cell preparations for medical, pharmaceutical or veterinary purposes and particularly for gene therapy and cell therapy;scientific work relating to basic research and applied research in particular in biopharmaceutical and bacteriological processing; research and development of new products for others, in particular, research and development of molecules for pharmaceutical industries; conducting screening tests to identify, characterize, validate or develop biologically active molecules; advising and consultancy in scientific field; licensing of intellectual property rights for others; quality control services;.

Its status is currently believed to be active. Its class is unavailable. “ENDOTIS” is believed to be currently owned by “BECHARD, David”.